Selinexor Treatment of Advanced Relapsed/Refractory Squamous Cell Carcinomas

NCT02213133 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
45
Enrollment
INDUSTRY
Sponsor class

Stopped Due to enrollment challenges and availability of other options for lung cancer patients. The termination is not a consequence of any safety concern.

Conditions

Interventions

Sponsor

Karyopharm Therapeutics Inc